A comprehensive view of Metabolic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly partners with Sosei Group to develop, commercialize small molecules that modulate novel G protein-coupled receptor targets associated with diabetes, metabolic diseases; firms to use Sosei Heptares' StaR technology and drug design platform
Published: December 20, 2022 by BioSpectrum Asia
Eli Lilly partners with biotech Nimbus Therapeutics to develop novel targeted therapies for metabolic diseases; Nimbus to use its computational drug discovery engine and Lily to assume development, global commercialization activities
Published: October 12, 2022 by SeeNews Pharmaceuticals
Amgen opens new 245,000 square-foot, nine-story R&D facility in San Francisco, California, with staff of 650; new facility to focus on discovering cancer, inflammatory disease, cardiometabolic disorder therapies
Published: October 07, 2022 by PR Newswire
Fitch upgrades Sanofi's outlook to positive from stable, reflecting its transition toward innovative pharmaceutical company and vaccine producer, away from cardio-metabolic leader with rare disease franchise, broad portfolio of legacy off-patent drugs
Published: May 24, 2022 by ENP Newswire
Abbott releasing 12 metabolic nutrition formulas previously on hold free of charge to patients; products were on hold following recall of some powdered infant formulas, with product manufacturing to resume at Sturgis, Michigan, plant pending FDA approval
Published: May 02, 2022 by Abbott Laboratories

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count